Descriptions:
| Term | description type | Language/acceptability | Language/acceptability | Case significance |
|---|---|---|---|---|
At [qualifier] risk of [event or finding] (finding) | FSN | us:P | gb:P | ci |
At [qualifier] risk of [event or finding] | SYN | us:P | gb:P | ci |
Concept model:
| Attribute Group Cardinality | Attribute Cardinality | Attribute in Group Cardinality | Attribute | Value |
|---|---|---|---|---|
| 0..0 | 1..1 | |||
| 0..1 | 1..1 | 1..1 | ||
| 0..1 | 1..1 | 1..1 | [finding or event] < 404684003 |Clinical finding (finding)| OR < 272379006 |Event (event)| | |
| 1..1 | 1..1 | 1..1 | ||
| 1..1 | 1..1 | [qualifier] < 272520006 |Degree findings (qualifier value)| | ||
| 0..1 | 0..1 | 1..1 | ||
| 0..1 | 1..1 |
Definition status:
900000000000073002 |Defined (core metadata concept)|
Applies to:
<< 281694009 |Finding of at risk (finding)|
Template Language
[[~0..1]] {[[~1..1]] 42752001 |Due to (attribute)| = [[+id (<< 404684003 |Clinical finding (finding)| ]]},
[[~0..1]] {[[~1..1]] 719722006 |Has realization (attribute)| = [[+id (< 404684003 |Clinical finding (finding)| OR < 272379006 |Event (event))]]}, [[~1..1]] { [[~1..1]] 363714003| Interprets (attribute) |= [[+id (1255619009| Risk level (observable entity) |)]], [[~1..1]] 363713009| Has interpretation (attribute) |= [[+id (<<272520006| Degree findings (qualifier value) |)]]} [[~0..1]] { [[~0..1]] 246454002| Occurrence (attribute) |= [[+id(<<282032007| Periods of life (qualifier value) |)]], [[~0..1]] 246075003| Causative agent (attribute) |= [[+id (< 105590001| Substance (substance) |)]]}|
Link to the misaligned concept report
Overdose misaligned concept report 2021-Dec-14
Rules for generating descriptions:
Editorial guidelines for selection of Causative agent attribute value:
The following editorial guidelines apply to concepts in the International Release; editorial guidelines for concepts in national extensions may vary.
| Hierarchy | Concept type | Allowed | Exception | Examples and Notes (Note: Examples are existing concepts and may not reflect the terming patterns described in the template.) |
|---|---|---|---|---|
| Substance | Base | yes | n/a | Example:
|
| Substance | Modification | yes | yes | Concepts representing substance modifications are exceptions and may be included if the overdose profile is significantly different from the substance base. Exception examples:
Example:
|
| Substance | Disposition grouper | yes | n/a | Overdose concepts representing a disposition grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example:
|
| Substance | Role grouper | yes | n/a | Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release. Example:
|
| Substance | Structure grouper | yes | n/a | Overdose concepts representing a structure grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Example:
|
| Product | Structure grouper | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
| Product | Disposition grouper | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
| Product | Role grouper | no | n/a | Overdose concepts representing a role grouper should be modeled using a Causative agent that is a descendant of 105590001 |Substance (substance)|. Role groupers will be transitioned to the 763158003 |Medicinal product (product)| hierarchy in a future release. |
| Product | Medicinal product-containing | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
| Product | Medicinal product-only | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
| Product | Medicinal product form-containing | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
| Product | Medicinal product form-only | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
| Product | Clinical drug | no | n/a | No use case has been identified for use of this concept type for modeling in this subhierarchy. |
The following types of groupers are out of scope; existing concepts have been inactivated or will be addressed in future release:
- Groupers based on more than one role (e.g. 292722006 |Chelating agents and antidotes adverse reaction (disorder)|)
- Groupers based on body system or intended site or route of administration (e.g. 292548001 |Drug groups primarily affecting respiratory system adverse reaction (disorder)|) or 417895009 |Topical agent adverse reaction (disorder)|)
- Groupers based on disposition, role, or structure combined with an individual substance (e.g. 287177000 |Sulfonamide/trimethoprim reaction (disorder)| or 292513008 |Methyldopa and diuretic adverse reaction (disorder)|)
- Groupers based on "combined" or "compound" substances (e.g. 292983008 |Combined penicillin preparation adverse reaction (disorder)| or 293358005 |Compound iron preparations adverse reaction (disorder)|)
- Groupers based on disposition or structure combined with intended site or route of administration (e.g. 433494006 |Adverse effect of oral diphosphonate (disorder)|)
Rules for description generation:
- For the FSN, align terming and case sensitivity with the FSN for the concept that is selected as the attribute value, excluding the semantic tag.
- For the PT, align terming and case sensitivity with the US and GB PT for the concept that is selected as the attribute value.
- In cases where neither the US or GB PT matches the FSN, excluding the semantic tag, a synonym corresponding to the FSN is required unless explicitly identified as an exception.
JIRA ticket for implementation:
INFRA-8098 - Getting issue details... STATUS